化工社化工社 化学情報印刷レポート · 研究参考用
リモナバント塩酸塩
リモナバント塩酸塩 · CS-1821 · ACOMPLIA · SR 141716A · SR 151716A · RIMONABANT HCL · Rimonabant ,98% · Acomplia, SR141716

識別子と物理属性
| CAS No. | 158681-13-1 |
|---|---|
| 分子式 | C22H22Cl4N4O |
| 平均分子量 | 500.2 g/mol |
| 単同位体質量 | 498.05477204 g/mol |
| SMILES | Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1.Cl |
| InChIKey | REOYOKXLUFHOBV-UHFFFAOYSA-N |
| PubChem CID | 104849 |
| ChEMBL | CHEMBL558598 |
| EC No. | 806-144-8 |
| DTXSID | DTXSID20166495 |
| 現地名 | リモナバント塩酸塩 |
化学・物理的性質
| 極性表面積 | 50.2 |
|---|---|
| 水素結合供与体数 | 2 |
| 水素結合受容体数 | 3 |
| 回転可能結合数 | 4 |
| 重原子数 | 31 |
| 形式電荷 | 0 |
| 複雑度 | 583 |
| 融点 | 230-240°C |
| 貯蔵条件 | 2-8°C |
| 溶解度 | DMSO:可溶20mg/mL、透明 |
| 外観・状態 | 粉 |
| 色 | 白からベージュ |
| InChI | 1S/C22H21Cl3N4O.ClH/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) |
| InChIKey | REOYOKXLUFHOBV-UHFFFAOYSA-N |
| SMILES | CC1=C(C2=CC=C(Cl)C=C2)N(C3=CC=C(Cl)C=C3Cl)N=C1C(NN4CCCCC4)=O.Cl |
| CAS データベース | 158681-13-1(CAS DataBase Reference) |
化学的特性
White to Off-White Crystalline Solid
安全性と法規制
| GHS 分類 | DangerH301 (97.5%): Toxic if swallowed [Danger Acute toxicity, oral]P264, P264+P265, P270, P280, P301+P316, P305+P351+P338, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 3 (97.5%) |
| 水環境危害等級(WGK) | 3 |
| 輸送番号(UN) | UN 2811 6.1 / PGIII |
| 危険文句(R) | 25-36 |
| 危険表示 | T,Xi |
| 安全措置(S) | 26-45 |
| 危険等級 | Acute Tox. 3 OralEye Irrit. 2 |
| 貯蔵分類 | 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects |
用途
使用
Rimonabant hydrochloride has been used as an antagonist of cannabinoid 1 (CB1) receptor:to study its effects on protein synthesis in C2C12 myotubesto analyze its effects on human astrogliain combination with methanandamide (mAEA) to study its effects on murine gastric vagal afferent mechanosensitivity